Instrument overview

FREFresenius SE & Co. KGaA

StockXetraGermanyHealth careEU retail: available

+0.2% today · −4.2% over a year

No score: too little data.

Dividend yield 2.27%.

Fresenius SE & Co. KGaA (FRE) belongs to the Health care sector and is listed on Xetra; country: Germany. Over the past 12 months the price changed by −4.2%, with an annualised volatility of 25% and a largest fall of 30%.

Not scored: not enough data for a fair comparison.

Factor scores

Price trend over the last 12 and 6 months (excluding the last month) and distance from the 52-week high. More in the glossary →better than 52% of peers
Lower price swings, lower market sensitivity (beta) and shallower drawdowns score higher. More in the glossary →better than 72% of peers

Percentiles within the peer group (100 = the best of its peers); dividend safety in points.

Main drivers

  • Volatility (1 y)supports the score · better than 88% of peers
  • Max drawdown (3 y)supports the score · better than 77% of peers
  • Betaweighs on the score · better than 30% of peers

Red flags and notes

No red flagsNone of our published warning rules is triggered right now.

Price chart

Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.

Key metrics

Dividends

Dividend yield
2.27%
5-year dividend growth (per year)
3.6%
Years of dividend growth
1

Returns and risk

1 day
+0.2%
1 month
−0.3%
1 year
−4.2%
Volatility, 1 yr
24.9%
Max drawdown, 1 yr
−30.1%
Beta
0.96

Returns are price changes from end-of-day prices, without dividends.

Similar companies

Same sector, closest in price swings over the past year.

SHLSiemens Healthineers AG—/102.3%−10.7%
GSKGSK plc10/103.7%11.4%
GSKGSK plc—/103.7%15.5%
STESTERIS9/101.1%−4.3%
PHIAKoninklijke Philips N.V.3/103.5%7.8%
RORoche Holding AG (bearer shares)—/102.7%52.9%
NOVNNovartis AG10/102.9%34.7%
RDYDr. Reddy's Laboratories—/101.0%−2.4%

News and filings

No recent news or filings in our sources.

Score changes in the last 12 months

Every published rating and change, logged when it was published (EU Market Abuse Regulation).

No published ratings in the last 12 months.